Streamex Secures $25 Million Convertible Debenture Financing

Streamex ( (STEX) ) has provided an update.

On December 17, 2025, Streamex Corp. entered into a fourth amendment to its Secured Convertible Debenture Purchase Agreement with institutional investor YA II PN, Ltd. (Yorkville), revising certain prior closing conditions without changing any material terms of the financing arrangements. On the same date, the company completed a second closing under the agreement, issuing a $25 million secured convertible debenture to Yorkville on terms broadly consistent with a prior tranche, generating approximately $24 million in gross proceeds at a 4% annual interest rate (rising to 18% upon default) and a maturity date of December 17, 2027; the instrument features a variable conversion price linked to the company’s volume‑weighted average share price, subject to anti‑dilution adjustments, a $4.00 per‑share conversion floor and a 4.99% ownership cap for the investor, as well as prepayment rights for Streamex with a 10% premium. The transaction, structured as a private offering exempt from SEC registration, provides Streamex with significant additional liquidity while introducing potential future equity dilution and preserving Yorkville’s ability to convert its debt into common stock within tightly defined pricing and ownership constraints, and follows a corporate update webinar the company hosted for investors on December 16, 2025.

The most recent analyst rating on (STEX) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.

Spark’s Take on STEX Stock

According to Spark, TipRanks’ AI Analyst, STEX is a Underperform.

BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.

To see Spark’s full report on STEX stock, click here.

More about Streamex

Streamex Corp., formerly known as BioSig Technologies, Inc., is a Delaware corporation whose common stock is registered with the U.S. Securities and Exchange Commission and is held by public investors, positioning the company within the regulated U.S. public markets.

Average Trading Volume: 1,007,857

Technical Sentiment Signal: Sell

Current Market Cap: $144.9M

See more data about STEX stock on TipRanks’ Stock Analysis page.